Frans Vossenburg
Interventional Cardiology · Fredericksbrg, VANPI 1881680619
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,021 and has fallen 84.9% since, to $154 in 2022. That places this record below the midpoint for interventional cardiology clinicians in VA, where the typical reported total is $4,743.
Across 100 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$270
- AstraZeneca$237
- Novartis$161
- Sanofi-aventis U.S. LLC$151
- Johnson & Johnson$120
- Bayer$83
- plus $496 from 19 others
What the payments were for
- Consulting fees$111%
- Food & beverage$1,50799%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $270 |
| AstraZeneca | 14 | $237 |
| Novartis | 17 | $161 |
| Sanofi-aventis U.S. LLC | 10 | $151 |
| Johnson & Johnson | 7 | $120 |
| Bayer | 4 | $83 |
| Pfizer | 6 | $81 |
| Amarin Pharma, Inc. | 4 | $63 |
| Portola Pharmaceuticals, LLC | 2 | $56 |
| Nuwellis, Inc. | 2 | $38 |
| United Therapeutics Corporation | 2 | $37 |
| Medtronic | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Astellas Pharma US Inc | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Abbott | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| B. Braun Interventional Systems Inc. | 1 | $14 |
| Penumbra, Inc. | 1 | $13 |
| Atricure, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Itamar Medical Inc | 1 | $11 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
How this compares
$1,518 in reported general payments places this provider in the 25th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Fredericksbrg
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
- Jason FoerstRoanoke$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.